Recent Updates
Recently added Catalysts
PHG Positive Sentiment

Samenvatting: Philips en Imricor lanceren een MR-laboratoriumoplossing voor hartingrepen en breiden daarmee hun langdurige samenwerking uit

Friday, August 28, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Royal Philips and Imricor Medical Systems have announced a new interventional MRI laboratory solution for Philips' 1.5T MRI scanners. This launch marks the first commercially available configuration of its kind, enhancing their long-term collaboration. The partnership aims to improve healthcare technology in interventional procedures.

Market Sentiment Analysis

POSITIVE FACTORS

  • Launch of a new laboratory solution for interventional MRI.
  • Collaboration between Philips and Imricor strengthens market position.
  • First commercially available configuration for 1.5T MRI scanners.

Full Press Release Details

AMSTERDAM--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), een wereldwijde marktleider op het gebied van gezondheidstechnologie, en Imricor Medical Systems (ASX: IMR), een pionier en toonaangevende ontwikkelaar van MR-compatibele producten voor interventionele MR-procedures, hebben vandaag een nieuwe laboratoriumoplossing voor interventionele MR (iMR) aangekondigd voor de 1,5T MR-scanners van Philips. Deze eerste commercieel beschikbare configuratie combineert het 1,5T MRI-platform van P

Frequently Asked Questions

What is the new solution launched by Philips and Imricor?

They launched a new interventional MRI laboratory solution for 1.5T MRI scanners.

What does the collaboration between Philips and Imricor entail?

The collaboration aims to enhance healthcare technology in interventional procedures.

Is this the first configuration of its kind?

Yes, it is the first commercially available configuration for interventional MRI.

ShareAdd on Google
Tags: PHG Viatris Investor Conferences Healthcare Philips Imricor MRI technology healthcare innovation medical devices
Last updated: Aug 28, 2026